Fulgent Genetics Inc.(FLGT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

FLGT Fulgent Genetics Inc.

盘前交易 09-02 06:36:48 EDT

19.59

+0.22

+1.14%

最高19.85	最低19.29	成交量28.56万
今开19.29	昨收19.37	日振幅2.89%
总市值5.39亿	流通市值3.23亿	总股本2,752万
成交额559.77万	换手率1.73%	流通股本1,648万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"FLGT","market":"US","secType":"STK","nameCN":"Fulgent Genetics Inc.","latestPrice":19.59,"timestamp":1788292800000,"preClose":19.37,"halted":0,"volume":285558,"delay":0,"changeRate":0.011357769747031433,"floatShares":16480041,"shares":27515293,"eps":-2.809369,"marketStatus":"盘前交易","change":0.22,"latestTime":"09-02 06:36:48 EDT","open":19.29,"high":19.85,"low":19.29,"amount":5597736.933516,"amplitude":0.028911,"askPrice":28.95,"askSize":100,"bidPrice":13.72,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.809369,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1788355800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1475121600000,"exchange":"NASDAQ","adjPreClose":19.59,"postHourTrading":{"tag":"盘后","latestPrice":19.59,"preClose":19.59,"latestTime":"19:30 EDT","volume":6356,"amount":124513.52,"timestamp":1788305400600,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.2216959947204045,"impliedVol":0.5625,"impliedVolPercentile":0.7012},"requestUrl":"/m/hq/s/FLGT","defaultTab":"news","newsList":[{"id":"1146688600","title":"Fulgent Genetics Inc. 预计2026年营收3.3亿至3.4亿美元，GAAP每股亏损约2.22至2.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1146688600","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1146688600?lang=zh_cn&edition=full","pubTime":"2026-07-31 04:20","pubTimestamp":1785442811,"startTime":"0","endTime":"0","summary":"Fulgent Genetics Inc. 近日发布业绩展望，预计2026年全年营收将在3.3亿至3.4亿美元之间。与此同时，公司预计按非公认会计准则（Non-GAAP）计算，每股亏损约为2.22至2.35美元。这一预测数据反映出公司对未来运营表现的审慎预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FLGT","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100337391","title":"Fulgent Genetics宣布Fid-007头颈癌研究完整摘要将于ASCO 2026年会头颈癌专题会议进行快速口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1100337391","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1100337391?lang=zh_cn&edition=full","pubTime":"2026-05-22 05:04","pubTimestamp":1779397481,"startTime":"0","endTime":"0","summary":"Fulgent Genetics公司宣布，其研究性药物Fid-007针对头颈癌的完整研究摘要，已被选定于2026年美国临床肿瘤学会（ASCO）年会头颈癌专题会议中进行快速口头报告。\n这一安排标志着该研究获得了国际顶级肿瘤学会议的高度关注，其数据将在这一全球肿瘤学界的盛会上进行正式展示与交流。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","FLGT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165323290","title":"异动解读 | Fulgent Genetics因财报疲软及资金流出股价遭重挫","url":"https://stock-news.laohu8.com/highlight/detail?id=1165323290","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165323290?lang=zh_cn&edition=full","pubTime":"2024-11-09 16:08","pubTimestamp":1731139718,"startTime":"0","endTime":"0","summary":"Fulgent Genetics Inc.今日盘中股价暴跌13.81%,引发市场广泛关注其跌势原因。\n\n该公司此前公布的最新季度财报显示,虽然实现每股收益0.31美元、超出分析师平均预期,但营收同比却下滑15.3%,并录得1465万美元亏损。由此可见,虽然公司最新财报表现勉强略超预期,但营收持续下滑、亏损加大的现状,令市场对其长期增长前景仍存疑虑。\n\n分析师目前对Fulgent Genetics主要给予\"持有\"评级,显示对公司未来发展看好程度不高。加之最新交易日内资金出现净流出,这或进一步加剧了股价跌势。综合来看,财报、分析师评级和资金流向等因素,都为公司盘中重挫埋下了伏笔。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["FLGT"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.fulgentgenetics.com","stockEarnings":[{"period":"1week","weight":-0.018},{"period":"1month","weight":0.1837},{"period":"3month","weight":0.0799},{"period":"6month","weight":0.3747},{"period":"1year","weight":-0.1164},{"period":"ytd","weight":-0.2543}],"compareEarnings":[{"period":"1week","weight":-0.0054},{"period":"1month","weight":0.0197},{"period":"3month","weight":0.01},{"period":"6month","weight":0.1181},{"period":"1year","weight":0.181},{"period":"ytd","weight":0.1171}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Fulgent Genetics, Inc.在2016年5月13日注册成立于美国特拉华州。该公司是一家以技术为基础的公司，拥有成熟的临床诊断业务和治疗开发业务。该公司临床诊断业务提供分子诊断检测服务、全面的基因检测和高质量的解剖病理实验室服务，旨在为医生和患者提供临床可操作的诊断信息，以提高患者护理质量。该公司的治疗开发业务专注于使用新型纳米封装和靶向治疗平台开发治疗多种癌症的候选药物，该平台旨在改善新的和现有癌症药物的治疗窗口和药代动力学特征，或PK特征。该公司的目标是从基因组诊断业务转型为一家完全整合的精准医疗公司。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.108175},{"month":2,"riseRate":0.3,"avgChangeRate":-0.052634},{"month":3,"riseRate":0.4,"avgChangeRate":-0.015487},{"month":4,"riseRate":0.3,"avgChangeRate":0.013636},{"month":5,"riseRate":0.5,"avgChangeRate":0.019131},{"month":6,"riseRate":0.6,"avgChangeRate":0.040989},{"month":7,"riseRate":0.6,"avgChangeRate":0.081477},{"month":8,"riseRate":0.4,"avgChangeRate":0.053367},{"month":9,"riseRate":0.3,"avgChangeRate":-0.023275},{"month":10,"riseRate":0.1,"avgChangeRate":-0.072376},{"month":11,"riseRate":0.6,"avgChangeRate":0.096806},{"month":12,"riseRate":0.7,"avgChangeRate":0.038713}],"exchange":"NASDAQ","name":"Fulgent Genetics Inc.","nameEN":"Fulgent Genetics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Fulgent Genetics Inc.(FLGT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Fulgent Genetics Inc.(FLGT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Fulgent Genetics Inc.,FLGT,Fulgent Genetics Inc.股票,Fulgent Genetics Inc.股票老虎,Fulgent Genetics Inc.股票老虎国际,Fulgent Genetics Inc.行情,Fulgent Genetics Inc.股票行情,Fulgent Genetics Inc.股价,Fulgent Genetics Inc.股市,Fulgent Genetics Inc.股票价格,Fulgent Genetics Inc.股票交易,Fulgent Genetics Inc.股票购买,Fulgent Genetics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Fulgent Genetics Inc.(FLGT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Fulgent Genetics Inc.(FLGT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}